Examination of apoptosis signaling in pancreatic cancer by computational signal transduction analysis

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Rückert, Felix ^a   Dawelbait, Gihan ^b   Winter, Christof ^b   Hartmann, Arndt ^c   Denz, Axel ^a   Ammerpohl, Ole ^d   Schroeder, Michael ^b   Schackert, Hans Konrad ^a   Sipos, Bence ^d   Klöppel, Günter ^d   Kalthoff, Holger ^d   Saeger, Hans Detlev ^a   Pilarsky, Christian ^a   Grützmann, Robert ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR TYPE II; LIVIN; PROTEIN BNIP3; SURVIVIN; TUMOR NECROSIS FACTOR RECEPTOR 1;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENETIC DATABASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MATHEMATICAL ANALYSIS; PANCREAS CANCER; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; BIOLOGY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; METHODOLOGY; PANCREAS TUMOR; PATHOLOGY; PHENOTYPE; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 77957917101     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012243     Document Type: Article

References (41)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Lowenfels AB, Maisonneuve P (2006) Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 20: 197-209.
3. Wolff RA, Chiao P, Lenzi R, Pisters PW, Lee JE, et al. (2000) Current approaches and future strategies for pancreatic carcinoma. Invest New Drugs 18: 43-56.
4. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806.
5. Brown JM, Attardi LD (2005) The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 5: 231-237.
6. Eccles SA, Welch DR (2007) Metastasis: recent discoveries and novel treatment strategies. Lancet 369: 1742-1757.
7. Rupnow BA, Knox SJ (1999) The role of radiation-induced apoptosis as a determinant of tumor responses to radiation therapy. Apoptosis 4: 115-143.
8. Rückert F, Pilarsky C, Saeger H, Grützmann R (2009) Apoptotic Signaling in Pancreatic Cancer - Therapeutic Application. Current Cancer Therapy Reviews 5: 122-133.
9. Heppner GH (1984) Tumor heterogeneity. Cancer Res 44: 2259-2265.
10. Ringel B, Ibrahim SM, Kohler H, Ringel J, Koczan D, et al. (1999) Apoptotic molecules in pancreatic carcinoma cell lines. Ann N Y Acad Sci 880: 175-178.
11. Bernstorff WV, Glickman JN, Odze RD, Farraye FA, Joo HG, et al. (2002) Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escape. Cancer 94: 2552-2560.
12. Ungefroren H, Voss M, Bernstorff WV, Schmid A, Kremer B, et al. (1999) Immunological escape mechanisms in pancreatic carcinoma. Ann N Y Acad Sci 880: 243-251.
13. Arlt A, Vorndamm J, Muerkoster S, Yu H, Schmidt WE, et al. (2002) Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines. Cancer Res 62: 910-916.
14. Dupraz P, Cottet S, Hamburger F, Dolci W, Felley-Bosco E, et al. (2000) Dominant negative MyD88 proteins inhibit interleukin-1beta/interferongamma -mediated induction of nuclear factor kappa B-dependent nitrite production and apoptosis in beta cells. J Biol Chem 275: 37672-37678.
15. Ruckdeschel K, Mannel O, Schrottner P (2002) Divergence of apoptosisinducing and preventing signals in bacteria-faced macrophages through myeloid differentiation factor 88 and IL-1 receptor-associated kinase members. J Immunol 168: 4601-4611.
16. Yoshida Y, Kumar A, Koyama Y, Peng H, Arman A, et al. (2004) Interleukin 1 activates STAT3/nuclear factor-kappaB cross-talk via a unique TRAF6- and p65-dependent mechanism. J Biol Chem 279: 1768-1776.
17. Matsuo Y, Sawai H, Funahashi H, Takahashi H, Sakamoto M, et al. (2004) Enhanced angiogenesis due to inflammatory cytokines from pancreatic cancer cell lines and relation to metastatic potential. Pancreas 28: 344-352.
18. Wright CW, Duckett CS (2005) Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function. J Clin Invest 115: 2673-2678.
19. Lopes RB, Gangeswaran R, McNeish IA, Wang Y, Lemoine NR (2007) Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy. Int J Cancer.
20. Fulda S, Debatin KM (2006) Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25: 4798-4811.
21. Schniewind B, Christgen M, Kurdow R, Haye S, Kremer B, et al. (2004) Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis. Int J Cancer 109: 182-188.
22. Jones DT (1999) GenTHREADER: an efficient and reliable protein fold recognition method for genomic sequences. J Mol Biol 287: 797-815.
23. Tsai CJ, Lin SL, Wolfson HJ, Nussinov R (1996) A dataset of protein-protein interfaces generated with a sequence-order-independent comparison technique. J Mol Biol 260: 604-620.
24. Winter C, Henschel A, Kim WK, Schroeder M (2006) SCOPPI: a structural classification of protein-protein interfaces. Nucleic Acids Res 34: D310-314.
25. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402.
26. Mishra GR, Suresh M, Kumaran K, Kannabiran N, Suresh S, et al. (2006) Human protein reference database--2006 update. Nucleic Acids Res 34: D411-414.
27. Grutzmann R, Pilarsky C, Ammerpohl O, Luttges J, Bohme A, et al. (2004) Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia 6: 611-622.
28. Pilarsky C, Ammerpohl O, Sipos B, Dahl E, Hartmann A, et al. (2008) Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling. J Cell Mol Med 12: 2823-2835.
29. Fink L, Seeger W, Ermert L, Hanze J, Stahl U, et al. (1998) Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 4: 1329-1333.
30. Stoehr R, Wissmann C, Suzuki H, Knuechel R, Krieg RC, et al. (2004) Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer. Lab Invest 84: 465-478.
31. Karikari CA, Roy I, Tryggestad E, Feldmann G, Pinilla C, et al. (2007) Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein. Mol Cancer Ther.
32. Vogler M, Durr K, Jovanovic M, Debatin KM, Fulda S (2007) Regulation of TRAIL-induced apoptosis by XIAP in pancreatic carcinoma cells. Oncogene 26: 248-257.
33. Miyamoto Y, Hosotani R, Wada M, Lee JU, Koshiba T, et al. (1999) Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in pancreatic cancers. Oncology 56: 73-82.
34. Shi X, Liu S, Kleeff J, Friess H, Buchler MW (2002) Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes. Oncology 62: 354-362.
35. Grutzmann R, Saeger HD, Luttges J, Schackert HK, Kalthoff H, et al. (2004) Microarray-based gene expression profiling in pancreatic ductal carcinoma: status quo and perspectives. Int J Colorectal Dis 19: 401-413.
36. Tsuji S, Hosotani R, Yonehara S, Masui T, Tulachan SS, et al. (2003) Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma. Int J Cancer 106: 17-25.
37. Bai J, Sui J, Demirjian A, Vollmer CM, Jr., Marasco W, et al. (2005) Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. Cancer Res 65: 2344-2352.
38. Yamamoto S, Tomita Y, Hoshida Y, Morooka T, Nagano H, et al. (2004) Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma. Clin Cancer Res 10: 2846-2850.
39. Mahon PC, Baril P, Bhakta V, Chelala C, Caulee K, et al. (2007) S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer. Cancer Res 67: 6786-6795.
40. Akada M, Crnogorac-Jurcevic T, Lattimore S, Mahon P, Lopes R, et al. (2005) Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer. Clin Cancer Res 11: 3094-3101.
41. Mori T, Doi R, Toyoda E, Koizumi M, Ito D, et al. (2005) Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancer. Surgery 138: 71-77.